Supplemental Figure 4 from An Oral Formulation of YK-4-279: Preclinical Efficacy and Acquired Resistance Patterns in Ewing Sarcoma

Authors :: Joseph A. Ludwig
James E. O'Dorisio
Kirk S. Culotta
Dannette K. Doolittle
Adrianna S. Buford
Rebecca L. Maywald
Ramani A. Aiyer
Vandhana Ramamoorthy
Brian A. Menegaz
Salah-Eddine Lamhamedi-Cherradi
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Supplemental Figure 4. Proteomic analysis of sensitive and resistant ES cell lines to YK-4-279

Tools